Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders

Stock Information for Antibe Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Antibe Therapeutics Inc.

Aequus Announces Giovanni Di Genova Joining Board of Directors
Aequus Announces Sale of Zimed PF to Luvo Medical Technologies
Aequus Reports First Quarter 2025 Financial Highlights
Aequus Provides Update and Reports Third Quarter 2024 Financial Highlights.
Aequus Provides Update and Reports Third Quarter 2024 Financial Highlights
Aequus Reports Second Quarter 2024 Financial Highlights and General Update
Aequus Provides Launch Update Zimed PF
Aequus Signs Exclusive Distribution Agreement with Advanced Ophthalmic Innovations for the PAUL Glaucoma Drainage Device in Canada

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.